Market Forecast and CAGR for Fluidized-bed Bioreactors
According to Fact.MR’s research, the fluidized-bed bioreactors market is expected to grow by xx percent between 2021 and 2031. According to Fact.MR’s research, the Fluidized-Bed Bioreactors market will grow steadily over the forecast period of 2021-2031, owing to increased research into its applications in the healthcare field.
What factors are driving the market for fluidized-bed bioreactors?
The growing demand for proper treatment of biological waste water generated in healthcare settings in order to maintain proper hygiene and protect both human health and the environment is propelling the fluidized bed-bioreactors market forward. Despite its longer time span, the activated sludge process is most commonly used to treat biological wastewater. This could be due to the fact that it is cost-effective.
Researchers at the University of Western Ontario developed a fluidized-bed bioreactor that, according to preliminary tests, was able to remove 90% of organic matter and 80% of nitrogen. This method also produces 1/3 the amount of sludge as the original widely used method.
The application of this bioreactor in bio-artificial liver systems is another intriguing factor that plays a key role in the market’s potential growth. “Encapsulated hepatocytes (liver cells) can be mass transferred to bio-artificial liver systems without causing cell damage.” According to a study published in PubMed Central, “this will aid in the treatment of liver ailments such as hepatic failure,” which is expected to boost market demand.
Can 3D cell cultures be grown in fluidized-bed bioreactors?
A scaled-down version of a regular fluidized-bed bioreactor can provide a more controlled and dynamic environment for the creation of various cell cultures, according to a study published in PubMed Central in 2020. This cell culture can also be used to create a 3D cell culture in which the tissues are more visible, allowing for a more thorough analysis of the culture.
For a more thorough analysis of the culture, in-vivo conditions can be reproduced more precisely and at a lower cost. Animal models can also be used less frequently in research studies. This will encourage researchers to continue developing products with broad applications in the healthcare setting, thereby increasing market demand.
Canada and the United States of America Market for fluidized-bed bioreactors
The United States’ healthcare system is well-known for its advanced infrastructure and high spending. Various regulatory rules and insurance policies are in place to regulate the country’s health-care system. The United States has also adopted a number of cost-effective measures to reduce their healthcare costs.
The presence of major players in the bioreactor market, such as Parr Instrument Company, will undoubtedly benefit the market, as increased research into the various applications of these bioreactors will undoubtedly have a positive impact on the market.
For List of Key Players and Full Segmentation, Ask for a Sample Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=6883